Related Experiment Video

Updated: Apr 18, 2026

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice
07:02

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice

Published on: August 23, 2019

7.9K

MiR-204-5p suppresses cell proliferation by inhibiting IGFBP5 in papillary thyroid carcinoma

Lianyong Liu1, Jingnan Wang1, Xiangqi Li1

  • 1Department of Endocrine, Shanghai Pudong Gongli Hospital, Shanghai 200135, China.

Biochemical and Biophysical Research Communications
|January 21, 2015
PubMed

Insights

MicroRNAs (miRNAs) like miR-204-5p suppress papillary thyroid carcinoma (PTC) growth by targeting IGFBP5. This finding suggests miR-204-5p as a potential therapeutic agent for PTC treatment.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • MicroRNAs (miRNAs) are crucial regulators of gene expression, frequently altered in human cancers.
  • miR-204-5p is notably downregulated in papillary thyroid carcinoma (PTC), but its functional role remains unclear.

Purpose of the Study:

  • To investigate the functional significance of miR-204-5p in papillary thyroid carcinoma.
  • To elucidate the molecular mechanisms underlying miR-204-5p's action in PTC.

Main Methods:

  • Overexpression of miR-204-5p in PTC cell lines.
  • Cell proliferation, cell cycle, and apoptosis assays.
  • Luciferase reporter assay to confirm direct target binding.
  • Insulin-like growth factor-binding protein 5 (IGFBP5) overexpression experiments.

Main Results:

  • Overexpression of miR-204-5p significantly inhibited PTC cell proliferation.
  • miR-204-5p induced cell cycle arrest and promoted apoptosis in PTC cells.
  • miR-204-5p directly targets the 3' untranslated region (UTR) of IGFBP5 mRNA.
  • IGFBP5 overexpression partially rescued the tumor-suppressive effects of miR-204-5p.

Conclusions:

  • miR-204-5p functions as a tumor suppressor in papillary thyroid carcinoma.
  • The tumor-suppressive activity of miR-204-5p is mediated through the regulation of IGFBP5 expression.
  • miR-204-5p holds potential as an antitumorigenic agent for PTC therapy.
Keywords:
IGFBP5Papillary thyroid carcinomaProliferationmiR-204-5p

More Related Videos

An In Vitro Protocol for Evaluating MicroRNA Levels, Functions, and Associated Target Genes in Tumor Cells09:45

An In Vitro Protocol for Evaluating MicroRNA Levels, Functions, and Associated Target Genes in Tumor Cells

Published on: May 21, 2019

9.1K
Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells06:54

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells

Published on: October 27, 2020

14.9K

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.5K
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
11.1K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
8.5K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
4.4K
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
6.4K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.3K